quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:10:08·101d
SECFiling
Axogen Inc. logo

Axogen Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

AXGN· Axogen Inc.
Health Care
Original source

Companies

  • AXGN
    Axogen Inc.
    Health Care

Recent analyst ratings

  • Feb 19UpdateWells Fargo$40.00
  • Dec 1UpdateMizuho$40.00
  • Mar 17UpdateLake Street$30.00
  • Jul 1UpdateRaymond James$13.00
  • Nov 11UpdateJefferies$15.00
  • May 9UpdateCanaccord Genuity$15.00

Related

  • PR3d
    CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
  • PR9d
    Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Axogen Inc.
  • INSIDER36d
    SEC Form 4 filed by Devinney Erick Wayne
  • INSIDER36d
    SEC Form 4 filed by Hartley Lindsey Marie
  • INSIDER52d
    Chief Marketing Officer Kemp Jens was granted 50,670 shares and covered exercise/tax liability with 18,366 shares, increasing direct ownership by 73% to 76,451 units (SEC Form 4)
  • INSIDER52d
    Chief Innovation Officer Devinney Erick Wayne was granted 33,780 shares and covered exercise/tax liability with 21,978 shares, increasing direct ownership by 5% to 252,934 units (SEC Form 4)
  • INSIDER52d
    EVP & General Counsel Began Marc A converted options into 11,250 shares, was granted 33,780 shares and covered exercise/tax liability with 13,180 shares, increasing direct ownership by 174% to 50,135 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022